• DMS

  Participated · Equity · Aug 2025

  DMS Group develops and produces systems for digital radiology and osteodensitometry and sells equipment internationally. The company employs around 60 people and reports consolidated revenues of €50 million, with approximately 80% generated from exports. DMS is present in more than 140 countries, including the United States, Norway, China and South Africa, and noted that it does not export to Canada or Japan due to regulatory and market considerations. Management plans to develop more autonomous radiology rooms that can take charge of patients and help address medical deserts and radiologist shortages, with artificial intelligence seen as a key enabler. The company intends to launch new imaging solutions between 2026 and 2030 and to use external financing to strengthen industrial capacity and regulatory readiness. The recent EIB participatory loan of up to €20 million is intended to support those development and commercialization efforts.

No current team members are available.